Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.

about

Suppression of Alzheimer's disease-related phenotypes by geranylgeranylacetone in mice

P2860

Q28533976-25AF52F7-6CB5-415B-BAF4-8DCE819C2174

P2860

Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.

Item

http://www.wikidata.org/entity/Q39692176

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Geranylgeranylacetone has anti ...... mTOR in human hepatoma cells.

@en

Geranylgeranylacetone has anti ...... mTOR in human hepatoma cells.

@nl

type

Item

label

Geranylgeranylacetone has anti ...... mTOR in human hepatoma cells.

@en

Geranylgeranylacetone has anti ...... mTOR in human hepatoma cells.

@nl

prefLabel

Geranylgeranylacetone has anti ...... mTOR in human hepatoma cells.

@en

Geranylgeranylacetone has anti ...... mTOR in human hepatoma cells.

@nl

P1476

Geranylgeranylacetone has anti ...... mTOR in human hepatoma cells.

@en

P2093

Eisuke Ozawa

http://www.w3.org/2001/XMLSchema#string

Fuminao Takeshima

http://www.w3.org/2001/XMLSchema#string

Hajime Isomoto

http://www.w3.org/2001/XMLSchema#string

Hisamitsu Miyaaki

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Nakao

http://www.w3.org/2001/XMLSchema#string

Masanori Ikeda

http://www.w3.org/2001/XMLSchema#string

Masashi Otani

http://www.w3.org/2001/XMLSchema#string

Motohisa Akiyama

http://www.w3.org/2001/XMLSchema#string

Naota Taura

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Kato

http://www.w3.org/2001/XMLSchema#string

P2860

HCV NS5A inhibits interferon-alpha signaling through suppression of STAT1 phosphorylation in hepatocyte-derived cell lines

Hepatitis C virus expression suppresses interferon signaling by degrading STAT1

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

Geranylgeranylacetone induces antiviral gene expression in human hepatoma cells.

Protective effect of geranylgeranylacetone, an inducer of heat shock protein 70, against drug-induced lung injury/fibrosis in an animal model

Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1.

Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection.

The hepatitis C virus life cycle as a target for new antiviral therapies.

Interferon-alpha-induced mTOR activation is an anti-hepatitis C virus signal via the phosphatidylinositol 3-kinase-Akt-independent pathway.

P304

195-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00535-011-0481-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22038554

http://www.w3.org/2001/XMLSchema#string

Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.

about

P2860

P2860

Geranylgeranylacetone has anti-hepatitis C virus activity via activation of mTOR in human hepatoma cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698